ab

Vaccine
Development Landscape

Wednesday 05th August 2020

11:00 EDT

Webinar

Register Now


About the Event

S Protein Reagents To Support SARS-CoV-2 Vaccine Development


COVID-19 pandemic is caused by a newly-discovered coronavirus, SARS-Cov-2. To characterize and detect this new virus, reagents, such as antibodies and antigens, to support scientific research, diagnosis and vaccine development are in urgent need. Sino Biological Inc uses internally-optimized HEK293 cells and other hosts to express S antigens with binding activity to ACE2, and also develops specific S and N antibodies to SARS-Cov-2 by several antibody generation platforms. Meanwhile, antibodies which have cross-reactivity to other strains of coronaviruses are under development and validation



Speaker

Speaker 3

Dr. Jiahui Yang

Director of R&D

Sino Biological Inc.



About Company

Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant antigen production and antibody development. The company’s ever-growing portfolio of products includes recombinant proteins, monoclonal antibodies, ELISA assay kits, expression clones, cell culture media, and other molecular biology tools. The company also offers a variety of customized services, mainly focusing on recombinant production of antigens and antibodies. Sino Biological is dedicated to virology and infectious disease research. Its newly launched ProVirTM collection is the world’s largest viral antigen bank, carrying over 800 products from 350 strains of viruses.

Agenda

Welcome Note

S protein reagents to support SARS-CoV-2 vaccine development

Speaker 3

Speaker

DR. JIAHUI YANG.

Director of R&D
Sino Biological Inc.

Q & A

Networking Session

End of Session

Sponsored By

Newsletter



          

Participation Form